Entity Wide Disclosures (Tables)

3 Months Ended

Mar. 31, 2022

Entity Wide Disclosures [Abstract]

Summary of Revenue by Major Source

The following table disaggregates our revenue by major source (in thousands):

	Three months Ended
	March 31,
	2022		2021
Therapeutic Area
Oncology	$	105,213	$	79,138
Other		70,417		68,938
Metabolic		48,116		32,495
Central Nervous System		38,487		24,812
Cardiology		37,396		23,762
AVAI		31,318		30,820
Total revenue	$	330,947	$	259,965